31 results on '"Maurer, Gerald"'
Search Results
2. Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent.
- Author
-
Dalos D, Gangl C, Roth C, Krenn L, Scherzer S, Vertesich M, Lang I, Maurer G, Neunteufl T, Berger R, and Delle-Karth G
- Subjects
- Adult, Aged, Angioplasty, Balloon, Coronary adverse effects, Cardiovascular Agents adverse effects, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease physiopathology, Everolimus adverse effects, Female, Humans, Male, Metals, Middle Aged, Predictive Value of Tests, Prosthesis Design, Retrospective Studies, Time Factors, Treatment Outcome, Absorbable Implants, Angioplasty, Balloon, Coronary instrumentation, Cardiovascular Agents administration & dosage, Coronary Artery Disease therapy, Coronary Vessels diagnostic imaging, Drug-Eluting Stents, Everolimus administration & dosage, Tomography, Optical Coherence
- Abstract
Background: Everolimus-eluting bioresorbable vascular scaffolds (BVS) represent an innovative treatment option for coronary artery disease. Clinical and angiographic results seem promising, however, data on its immediate procedural performance are still scarce. The aim of our study was to assess the mechanical properties of BVS by Optical Coherence Tomography (OCT) in clinical routine., Methods: Post-implantation OCT images of 40 BVS were retrospectively compared to those of 40 metallic everolimus-eluting stents (EES). Post-procedural device related morphological features were assessed. This included incidences of gross underexpansion and the stent eccentricity index (SEI, minimum/maximum diameter) as a measure for focal radial strength., Results: Patients receiving BVS were younger than those with EES (54.0 ± 11.2 years versus 61.7 ± 11.4 years, p = 0.012), the remaining baseline, vessel and lesion characteristics were comparable between groups. Lesion pre-dilatation was more frequently performed and inflation time was longer in the BVS than in the EES group (n = 34 versus n = 23, p = 0.006 and 44.2 ± 12.8 versus 25.6 ± 8.4 seconds, p < 0.001, respectively). There were no significant differences in maximal inflation pressures and post-dilatation frequencies with non-compliant balloons between groups. Whereas gross device underexpansion was not significantly different, SEI was significantly lower in the BVS group (n = 12 (30 %) versus n = 14 (35 %), p = 0.812 and 0.69 ± 0.08 versus 0.76 ± 0.09, p < 0.001, respectively). There was no difference in major adverse cardiac event-rate at six months., Conclusion: Our data show that focal radial expansion was significantly reduced in BVS compared to EES in a clinical routine setting using no routine post-dilatation protocol. Whether these findings have impact on scaffold mid-term results as well as on clinical outcome has to be investigated in larger, randomized trials.
- Published
- 2016
- Full Text
- View/download PDF
3. Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease - An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy.
- Author
-
Roth C, Gangl C, Dalos D, Krenn L, Scherzer S, Gerken A, Reinwein M, Zhang C, Hagmann M, Wrba T, Delle-Karth G, Neunteufl T, Maurer G, Vock P, Mayr H, Frey B, and Berger R
- Subjects
- Aged, Cohort Studies, Coronary Artery Disease mortality, Female, Humans, Male, Middle Aged, Treatment Outcome, Age Factors, Coronary Artery Disease surgery, Percutaneous Coronary Intervention, Survival Analysis
- Abstract
Background: Age is a strong predictor of survival in patients with coronary artery disease. In elder patients with increasing co-morbidities percutaneous coronary intervention (PCI) is associated with more complications and worse outcome. The calculation of relative survival rates adjusts for the "background" mortality in the general population by correcting for age and gender. We analyzed if elder patients after elective PCI have a worse relative survival compared to younger patient groups., Methods: A total of 8,342 patients who underwent elective PCI at two high volume centers between 1998 and 2009 were analyzed., Results: The survival of our patients after PCI (observed survival) was slightly lower compared to the general population (expected survival) resulting in a slightly decreasing relative survival curve. In a multivariate Cox regression model age amongst others was a strong predictor of survival. Stratifying patients according to their age the relative survival curves of younger patients (Quartile 1: <58 years; 2,046 patients), elder patients (Quartile 3: 66-73 years; 2,090 patients) and very old patients (Quartile 4: >73 years; 2,307 patients) were similar. The relative survival of mid-aged patients (Quartile 2: 58-65 years; 1,899 patients) was better than that of all other patient groups. The profile of cardiovascular risk factors differs between the various groups resulting in different composition and burden of coronary plaques in an optical coherence tomography sub-study., Conclusion: Patients after elective PCI have a slightly worse long-term survival compared to the age- and sex-matched general population. This is also true for different groups of age except for mid-aged patients between 58 and 63 years. Elder patients between 66 and 73 years and above 73 years have a similar relative survival compared to younger patients below 58 years, and might therefore have similar benefit from elective PCI.
- Published
- 2016
- Full Text
- View/download PDF
4. G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
- Author
-
Katsaros KM, Speidl WS, Demyanets S, Kastl SP, Krychtiuk KA, Wonnerth A, Zorn G, Tentzeris I, Farhan S, Maurer G, Wojta J, and Huber K
- Subjects
- Aged, Coronary Artery Disease physiopathology, Female, Granulocyte Colony-Stimulating Factor blood, Humans, Male, Middle Aged, Myocardial Infarction physiopathology, Coronary Artery Disease complications, Granulocyte Colony-Stimulating Factor physiology, Myocardial Infarction complications
- Abstract
Granulocyte-colony-stimulating-factor (G-CSF) induces mobilization of progenitor cells but may also exert pro-inflammatory and pro-thrombotic effects. Treatment with recombinant G-CSF after acute myocardial infarction is currently under examination and has been associated with in-stent restenosis. However, it is not known whether plasma levels of endogenous G-CSF are also associated with an increased cardiovascular risk. Therefore we included 280 patients with angiographically proven stable coronary artery disease. G-CSF was measured by specific ELISA and patients were followed for a median of 30 months for the occurrence of major adverse cardiovascular events (MACE: death, myocardial infarction, re-hospitalization). Those with cardiac events during follow-up showed significant higher G-CSF levels (32.3 pg/mL IQR 21.4-40.5 pg/mL vs. 24.6 pg/mL IQR 16.4-34.9 pg/mL; p<0.05) at baseline. Patients with G-CSF plasma levels above the median had a 2-fold increased risk for MACE (p<0.05). This was independent from established cardiovascular risk factors. In addition, G-CSF above the median was a predictor of clinical in-stent restenosis after implantation of bare-metal stents (6.6% vs. 19.4%; p<0.05) but not of drug-eluting stents (7.7% vs. 7.6%; p = 0.98). This data suggests that endogenous plasma levels of G-CSF predict cardiovascular events independently from established cardiac risk factors and are associated with increased in-stent restenosis rates after implantation of bare metal stents.
- Published
- 2015
- Full Text
- View/download PDF
5. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).
- Author
-
Krychtiuk KA, Kastl SP, Hofbauer SL, Wonnerth A, Goliasch G, Ozsvar-Kozma M, Katsaros KM, Maurer G, Huber K, Dostal E, Binder CJ, Pfaffenberger S, Oravec S, Wojta J, and Speidl WS
- Subjects
- Aged, Apolipoprotein B-100 blood, Atherosclerosis pathology, Cell Lineage, Coronary Artery Disease pathology, Female, GPI-Linked Proteins blood, Humans, Lipopolysaccharide Receptors blood, Lipoprotein(a) blood, Male, Middle Aged, Monocytes pathology, Phospholipids blood, Receptors, IgG blood, Risk Factors, Atherosclerosis blood, Coronary Artery Disease blood, Monocytes metabolism, Oxidation-Reduction
- Abstract
Background: Lipoprotein(a) (Lp(a)) is a proatherogenic plasma lipoprotein currently established as an independent risk factor for the development of atherosclerotic disease and as a predictor for acute thrombotic complications. In addition, Lp(a) is the major carrier of proinflammatory oxidized phospholipids (OxPL). Today, atherosclerosis is considered to be an inflammatory disease of the vessel wall in which monocytes and monocyte-derived macrophages are crucially involved. Circulating monocytes can be divided according to their surface expression pattern of CD14 and CD16 into at least 3 subsets with distinct inflammatory and atherogenic potential., Objective: The aim of this study was to examine whether elevated levels of Lp(a) and OxPL on apolipoprotein B-100-containing lipoproteins (OxPL/apoB) are associated with changes in monocyte subset distribution., Methods: We included 90 patients with stable coronary artery disease. Lp(a) and OxPL/apoB were measured, and monocyte subsets were identified as classical monocytes (CMs; CD14++CD16-), intermediate monocytes (IMs; CD14++CD16+), and nonclassical monocytes (NCMs; CD14+CD16++) by flow cytometry., Results: In patients with elevated levels of Lp(a) (>50 mg/dL), monocyte subset distribution was skewed toward an increase in the proportion of IM (7.0 ± 3.8% vs 5.2 ± 3.0%; P = .026), whereas CM (82.6 ± 6.5% vs 82.0 ± 6.8%; P = .73) and NCM (10.5 ± 5.3 vs 12.8 ± 6.0; P = .10) were not significantly different. This association was independent of clinical risk factors, choice of statin treatment regime, and inflammatory markers. In addition, OxPL/apoB was higher in patients with elevated Lp(a) and correlated with IM but not CM and NCM., Conclusions: In conclusion, we provide a potential link between elevated levels of Lp(a) and a proatherogenic distribution of monocyte subtypes in patients with stable atherosclerotic disease., (Copyright © 2015 National Lipid Association. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
6. Impaired antioxidant HDL function is associated with premature myocardial infarction.
- Author
-
Distelmaier K, Wiesbauer F, Blessberger H, Oravec S, Schrutka L, Binder C, Dostal E, Schillinger M, Wojta J, Lang IM, Maurer G, Huber K, and Goliasch G
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Antioxidants metabolism, Case-Control Studies, Cholesterol, HDL metabolism, Female, Humans, Male, Middle Aged, Risk Factors, Young Adult, Antioxidants physiology, Cholesterol, HDL physiology, Coronary Artery Disease complications, Myocardial Infarction etiology
- Abstract
Background: There is growing evidence that the predictive value of HDL cholesterol levels for cardiovascular risk stratification is limited in patients with coronary artery disease (CAD). HDL function seems to be a more sensitive surrogate of cardiovascular risk estimation than simple serum levels. Therefore, we aimed to assess whether impaired antioxidant HDL function is involved in the development of premature acute myocardial infarction (AMI)., Methods: In this multicentre case-control study, we compared the antioxidant function of HDL, measured by the HDL inflammatory index (HII), and HDL particle size in 184 patients comprising 92 patients with AMI at a very young age (≤40 years of age) and 92 age- and gender-matched controls., Results: Antioxidant capacities of HDL were significantly impaired in the acute phase of AMI (HII of 1·50 [IQR 1·10-1·74] vs. 0·56 [IQR 0·41-0·86] in controls, P < 0·001 as well as in the chronic stable phase 1 year after the event (HII of 0·85 [IQR 0·72-1·03] vs. 0·56 [IQR 0·41-0·86], P < 0·001) compared to controls. Moreover, HDL function in the stable phase remained significantly associated with premature MI in adjusted logistic regression analysis with an OR of 2·24 per SD increase of HII (95% CI 1·28-3·91; P = 0·005). Analyses of HDL size revealed a significant correlation between all HDL subfractions and HDL function in controls, whereas this correlation was lost for large and intermediate HDL in AMI patients., Conclusion: Impaired antioxidant function of HDL is independently associated with the development of premature AMI. The maintenance of HDL function might evolve into a significant therapeutic target, especially in patients with premature CAD., (© 2015 Stichting European Society for Clinical Investigation Journal Foundation.)
- Published
- 2015
- Full Text
- View/download PDF
7. Transcoronary sinus catheter interventions: back in the repertoire?
- Author
-
Mohl W, Milasinovic D, and Maurer G
- Subjects
- Female, Humans, Male, Anterior Wall Myocardial Infarction therapy, Balloon Occlusion, Cardiac Catheterization methods, Coronary Artery Disease therapy, Coronary Circulation, Coronary Sinus physiopathology, Percutaneous Coronary Intervention, Venous Pressure
- Published
- 2015
- Full Text
- View/download PDF
8. Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease.
- Author
-
Krychtiuk KA, Kastl SP, Pfaffenberger S, Lenz M, Hofbauer SL, Wonnerth A, Koller L, Katsaros KM, Pongratz T, Goliasch G, Niessner A, Gaspar L, Huber K, Maurer G, Dostal E, Wojta J, Oravec S, and Speidl WS
- Subjects
- Aged, Coronary Angiography, Cross-Sectional Studies, Female, Flow Cytometry, Humans, Male, Middle Aged, Biomarkers analysis, Coronary Artery Disease blood, Coronary Artery Disease pathology, Lipoproteins, LDL blood, Monocytes pathology
- Abstract
Objective: Atherosclerosis is considered to be an inflammatory disease in which monocytes and monocyte-derived macrophages play a key role. Circulating monocytes can be divided into three distinct subtypes, namely in classical monocytes (CM; CD14++CD16-), intermediate monocytes (IM; CD14++CD16+) and non-classical monocytes (NCM; CD14+CD16++). Low density lipoprotein particles are heterogeneous in size and density, with small, dense LDL (sdLDL) crucially implicated in atherogenesis. The aim of this study was to examine whether monocyte subsets are associated with sdLDL serum levels., Methods: We included 90 patients with angiographically documented stable coronary artery disease and determined monocyte subtypes by flow cytometry. sdLDL was measured by an electrophoresis method on polyacrylamide gel., Results: Patients with sdLDL levels in the highest tertile (sdLDL≥4mg/dL;T3) showed the highest levels of pro-inflammatory NCM (15.2±7% vs. 11.4±6% and 10.9±4%, respectively; p<0.01) when compared with patients in the middle (sdLDL=2-3mg/dL;T2) and lowest tertile (sdLDL=0-1mg/dL;T1). Furthermore, patients in the highest sdLDL tertile showed lower CM levels than patients in the middle and lowest tertile (79.2±8% vs. 83.9±7% and 82.7±5%; p<0.01 for T3 vs. T2+T1). Levels of IM were not related to sdLDL levels (5.6±4% vs. 4.6±3% vs. 6.4±3% for T3, T2 and T1, respectively). In contrast to monocyte subset distribution, levels of circulating pro- and anti-inflammatory markers were not associated with sdLDL levels., Conclusion: The atherogenic lipoprotein fraction sdLDL is associated with an increase of NCM and a decrease of CM. This could be a new link between lipid metabolism dysregulation, innate immunity and atherosclerosis.
- Published
- 2015
- Full Text
- View/download PDF
9. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.
- Author
-
Krychtiuk KA, Kastl SP, Pfaffenberger S, Pongratz T, Hofbauer SL, Wonnerth A, Katsaros KM, Goliasch G, Gaspar L, Huber K, Maurer G, Dostal E, Oravec S, Wojta J, and Speidl WS
- Subjects
- Aged, Atherosclerosis, Atorvastatin, Blood Pressure, Coronary Angiography, Cross-Sectional Studies, Female, Fluorobenzenes therapeutic use, Granulocyte Colony-Stimulating Factor metabolism, Granulocyte-Macrophage Colony-Stimulating Factor metabolism, Heptanoic Acids therapeutic use, Humans, Inflammation, Interleukin-10 metabolism, Lipids chemistry, Macrophage Colony-Stimulating Factor metabolism, Male, Middle Aged, Pyrimidines therapeutic use, Pyrroles therapeutic use, Risk Factors, Rosuvastatin Calcium, Sulfonamides therapeutic use, Coronary Artery Disease blood, Lipoproteins, HDL blood, Monocytes cytology
- Abstract
Objective: High-density lipoprotein (HDL) particles are heterogeneous in structure and function and the role of HDL subfractions in atherogenesis is not well understood. It has been suggested that small HDL may be dysfunctional in patients with coronary artery disease (CAD). Monocytes are considered to play a key role in atherosclerotic diseases. Circulating monocytes can be divided into three subtypes according to their surface expression of CD14 and CD16. Our aim was to examine whether monocyte subsets are associated with HDL subfractions in patients with atherosclerosis., Methods: We included 90 patients with angiographically stable CAD. Monocyte subsets were defined as classical monocytes (CD14++CD16-; CM), intermediate monocytes (CD14++CD16+; IM) and non-classical monocytes (CD14+CD16++; NCM). HDL subfractions were measured by electrophoresis on polyacrylamide gel., Results: Serum levels of small HDL correlated with circulating pro-inflammatory NCM and showed an inverse relationship to circulating CM independently from other lipid parameters, risk factors, inflammatory parameters or statin treatment regime, respectively. IM were not associated with small HDL. In particular, patients with small HDL levels in the highest tertile showed dramatically increased levels of NCM (14.7 ± 7% vs. 10.7 ± 5% and 10.8 ± 5%; p = 0.006) and a decreased proportion of CM (79.3 ± 7% vs. 83.7 ± 6% and 83.9 ± 6%; p = 0.004) compared to patients in the two lower tertiles. In contrast, intermediate HDL, large HDL and total HDL were not associated with monocyte subset distribution., Conclusion: Small HDL levels are associated with pro-inflammatory NCM and inversely correlated with CM. This may suggest that small HDL could have dysfunctional anti-inflammatory properties in patients with established CAD., (Copyright © 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
10. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.
- Author
-
Krenn L, Kopp C, Glogar D, Lang IM, Delle-Karth G, Neunteufl T, Kreiner G, Kaider A, Bergler-Klein J, Khorsand A, Nikfardjam M, Laufer G, Maurer G, and Gyöngyösi M
- Subjects
- Adult, Aged, Coronary Artery Bypass methods, Coronary Artery Disease economics, Cost-Benefit Analysis, Female, Follow-Up Studies, Humans, Male, Middle Aged, Percutaneous Coronary Intervention methods, Prospective Studies, Time Factors, Treatment Outcome, Coronary Artery Bypass economics, Coronary Artery Disease surgery, Drug-Eluting Stents, Hospital Costs, Percutaneous Coronary Intervention economics
- Abstract
Objectives: Cost-effectiveness of percutaneous coronary intervention (PCI) using drug-eluting stents (DES), and coronary artery bypass surgery (CABG) was analyzed in patients with multivessel coronary artery disease over a 5-year follow-up., Background: DES implantation reducing revascularization rate and associated costs might be attractive for health economics as compared to CABG., Methods: Consecutive patients with multivessel DES-PCI (n = 114, 3.3 ± 1.2 DES/patient) or CABG (n = 85, 2.7 ± 0.9 grafts/patient) were included prospectively. Primary endpoint was cost-benefit of multivessel DES-PCI over CABG, and the incremental cost-effectiveness ratio (ICER) was calculated. Secondary endpoint was the incidence of major adverse cardiac and cerebrovascular events (MACCE), including acute myocardial infarction (AMI), all-cause death, revascularization, and stroke., Results: Despite multiple uses for DES, in-hospital costs were significantly less for PCI than CABG, with 4551 €/patient difference between the groups. At 5-years, the overall costs remained higher for CABG patients (mean difference 5400 € between groups). Cost-effectiveness planes including all patients or subgroups of elderly patients, diabetic patients, or Syntax score >32 indicated that CABG is a more effective, more costly treatment mode for multivessel disease. At the 5-year follow-up, a higher incidence of MACCE (37.7% vs. 25.8%; log rank P = 0.048) and a trend towards more AMI/death/stroke (25.4% vs. 21.2%, log rank P = 0.359) was observed in PCI as compared to CABG. ICER indicated 45615 € or 126683 € to prevent one MACCE or AMI/death/stroke if CABG is performed., Conclusions: Cost-effectiveness analysis of DES-PCI vs. CABG demonstrated that CABG is the most effective, but most costly, treatment for preventing MACCE in patients with multivessel disease., (© 2014 The Authors. Catheterization and Cardiovascular Interventions. Published by Wiley Periodicals, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
11. Interplay between genetic and clinical variables affecting platelet reactivity and cardiac adverse events in patients undergoing percutaneous coronary intervention.
- Author
-
Siller-Matula JM, Lang IM, Neunteufl T, Kozinski M, Maurer G, Linkowska K, Grzybowski T, Kubica J, and Jilma B
- Subjects
- Aged, Coronary Artery Disease mortality, Coronary Artery Disease physiopathology, Cytochrome P-450 CYP2C19 genetics, Female, Humans, Male, Middle Aged, Platelet Activation, Polymorphism, Single Nucleotide, Proportional Hazards Models, Prospective Studies, Risk, Treatment Outcome, Coronary Artery Disease genetics, Coronary Artery Disease surgery, Percutaneous Coronary Intervention, Platelet Aggregation
- Abstract
Several clinical and genetic variables are associated with influencing high on treatment platelet reactivity (HTPR). The aim of the study was to propose a path model explaining a concurrent impact among variables influencing HTPR and ischemic events. In this prospective cohort study polymorphisms of CYP2C19*2, CYP2C19*17, ABCB1, PON1 alleles and platelet function assessed by Multiple Electrode Aggregometry were assessed in 416 patients undergoing percutaneous coronary intervention treated with clopidogrel and aspirin. The rates of major adverse cardiac events (MACE) were recorded during a 12-month follow up. The path model was calculated by a structural equation modelling. Paths from two clinical characteristics (diabetes mellitus and acute coronary syndrome (ACS)) and two genetic variants (CYP2C19*2 and CYP2C19*17) independently predicted HTPR (path coefficients: 0.11 0.10, 0.17, and -0.10, respectively; p<0.05 for all). By use of those four variables a novel score for prediction of HTPR was built: in a factor-weighted model the risk for HTPR was calculated with an OR of 3.8 (95%CI: 3.1-6.8, p<0.001) for a score level of ≥1 compared with a score of <1. While MACE was independently predicted by HTPR and age in the multivariate model (path coefficient: 0.14 and 0.13, respectively; p<0.05), the coexistence of HTPR and age ≥75 years emerged as the strongest predictor of MACE. Our study suggests a pathway, which might explain indirect and direct impact of variables on clinical outcome: ACS, diabetes mellitus, CYP2C19*2 and CYP2C19*17 genetic variants independently predicted HTPR. In turn, age ≥75 years and HTPR were the strongest predictors of MACE.
- Published
- 2014
- Full Text
- View/download PDF
12. An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents.
- Author
-
Katsaros KM, Kastl SP, Krychtiuk KA, Hutter R, Zorn G, Maurer G, Huber K, Wojta J, Christ G, and Speidl WS
- Subjects
- Aged, Coronary Angiography, Coronary Artery Disease blood, Coronary Artery Disease diagnostic imaging, Coronary Restenosis diagnostic imaging, Female, Humans, Male, Middle Aged, Percutaneous Coronary Intervention adverse effects, Prospective Studies, Risk Factors, Time Factors, Up-Regulation, Coronary Artery Disease therapy, Coronary Restenosis blood, Coronary Restenosis etiology, Drug-Eluting Stents, Percutaneous Coronary Intervention instrumentation, Vascular Endothelial Growth Factor A blood
- Abstract
Aims: Drug-eluting stents (DES) reduce late lumen loss compared to bare metal stents but were not able to eradicate in-stent restenosis (ISR) fully. Vascular endothelial growth factor (VEGF) may inhibit late lumen loss through accelerated reendothelialisation, but may also promote neointima formation by proinflammatory effects. The aim of this study was to evaluate whether endogenous plasma levels of VEGF are associated with development of ISR after implantation of DES., Methods and Results: We studied 85 patients who were treated with 159 DES. VEGF plasma levels were determined before and 24 hours after PCI. During the eight-month follow-up period, two patients (2.4%) died of cardiovascular causes and 12 patients (14.5% of patients, 7.6% of stents) developed angiographic ISR. Basal VEGF plasma levels were not different in patients with and without ISR at follow-up. In contrast to patients without ISR, VEGF increased significantly upon PCI in patients with ISR (p<0.005). Patients with a decrease of VEGF after PCI had a restenosis rate of 2.4% compared to a restenosis rate of 26.2% in patients with an increase of VEGF after the procedure (p<0.05). This was independent from clinical and angiographic risk factors., Conclusions: Basal plasma levels of VEGF are not associated with the development of ISR. However, an increase of VEGF after PCI is associated with a dramatically increased ISR rate after implantation of DES.
- Published
- 2014
- Full Text
- View/download PDF
13. Association between the rs342293 polymorphism and adverse cardiac events in patients undergoing percutaneous coronary intervention.
- Author
-
Siller-Matula JM, Arbesu I, Jilma B, Maurer G, Lang IM, and Mannhalter C
- Subjects
- Aged, Chromosomes, Human, Pair 7 genetics, Cohort Studies, Coronary Artery Disease blood, Female, Gene Frequency, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors therapeutic use, Prognosis, Prospective Studies, Stents, Coronary Artery Disease genetics, Coronary Artery Disease therapy, Mean Platelet Volume, Percutaneous Coronary Intervention adverse effects, Polymorphism, Single Nucleotide
- Abstract
The single nucleotide polymorphism (SNP) rs342293 has been shown to influence platelet number and mean platelet volume (MPV). We investigated the association between the rs342293 polymorphism and cardiovascular outcome in a prospective cohort study. The rs342293 polymorphism was analysed in 404 patients with coronary artery disease undergoing percutaneous coronary intervention. The rates of cardiac adverse events were recorded during two years of follow-up. The polymorphism was associated with MPV (median 10.1 fL, interquartile range [IQR]: 9.6 to 10.6 in patients with the CC-allele vs 10.4 fL, IQR: 9.9 to 11.1 in G>C SNP carriers; p<0.001), but not with platelet count. Survival analysis indicated that carriers of the rs342293 G variant had a substantially higher risk to develop cardiac adverse events compared with wild type carriers during two years of follow-up (33% vs 22%; adjusted hazard ratio = 1.63, 95% confidence interval = 1.06-2.52, p=0.027). The rs342293 SNP could explain 2.9% of the variability in MPV (p=0.01). In conclusion, patients undergoing coronary stenting who carry the G-variant of the rs342293 SNP which is associated with larger MPV are at higher risk for adverse cardiovascular outcome.
- Published
- 2014
- Full Text
- View/download PDF
14. Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score.
- Author
-
Goliasch G, Kleber ME, Richter B, Plischke M, Hoke M, Haschemi A, Marculescu R, Endler G, Grammer TB, Pilz S, Tomaschitz A, Silbernagel G, Maurer G, Wagner O, Huber K, März W, Mannhalter C, and Niessner A
- Subjects
- Aged, Austria epidemiology, Coronary Artery Disease blood, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prognosis, Prospective Studies, Risk Assessment, Risk Factors, Biomarkers blood, Coronary Artery Disease mortality
- Abstract
Aims: Previous risk assessment scores for patients with coronary artery disease (CAD) have focused on primary prevention and patients with acute coronary syndrome. However, especially in stable CAD patients improved long-term risk prediction is crucial to efficiently apply measures of secondary prevention. We aimed to create a clinically applicable mortality prediction score for stable CAD patients based on routinely determined laboratory biomarkers and clinical determinants of secondary prevention., Methods and Results: We prospectively included 547 patients with stable CAD and a median follow-up of 11.3 years. Independent risk factors were selected using bootstrapping based on Cox regression analysis. Age, left ventricular function, serum cholinesterase, creatinine, heart rate, and HbA1c were selected as significant mortality predictors for the final multivariable model. The Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score based on the aforementioned variables demonstrated an excellent discriminatory power for 10-year survival with a C-statistic of 0.77 (P < 0.001), which was significantly better than an established risk score based on conventional cardiovascular risk factors (C-statistic = 0.61, P < 0.001). Net reclassification confirmed a significant improvement in individual risk prediction by 34.8% (95% confidence interval: 21.7-48.0%) compared with the conventional risk score (P < 0.001). External validation of the risk score in 1275 participants of the Ludwigshafen Risk and Cardiovascular Health study (median follow-up of 9.8 years) achieved similar results (C-statistic = 0.73, P < 0.001)., Conclusion: The VILCAD score based on a routinely available set of risk factors, measures of cardiac function, and comorbidities outperforms established risk prediction algorithms and might improve the identification of high-risk patients for a more intensive treatment.
- Published
- 2012
- Full Text
- View/download PDF
15. Time course of endothelium-dependent and -independent coronary vasomotor response to coronary balloons and stents. Comparison of plain and drug-eluting balloons and stents.
- Author
-
Plass CA, Sabdyusheva-Litschauer I, Bernhart A, Samaha E, Petnehazy O, Szentirmai E, Petrási Z, Lamin V, Pavo N, Nyolczas N, Jakab A, Murlasits Z, Bergler-Klein J, Maurer G, and Gyöngyösi M
- Subjects
- Analysis of Variance, Animals, Coronary Artery Disease drug therapy, Disease Models, Animal, Swine, Time Factors, Angioplasty, Balloon, Coronary, Coronary Artery Disease therapy, Coronary Vasospasm pathology, Drug-Eluting Stents, Endothelium, Vascular pathology
- Abstract
Objectives: This study sought to determine the time dependency of the endothelium-dependent and -independent vascular responses after percutaneous coronary intervention (PCI) with drug-eluting (DEB) or plain balloons, bare-metal (BMS), and drug-eluting (DES) stents, or controls., Background: Long-term endothelial dysfunction after DES implantation is associated with delayed healing and late thrombosis., Methods: Domestic pigs underwent PCI using DEB or plain balloon, BMS, or DES. The dilated and stented segments, and the proximal reference segments of stents and control arteries were explanted at 5-h, 24-h, 1-week, and 1-month follow-up (FUP). Endothelin-induced vasoconstriction and endothelium-dependent and -independent vasodilation of the arterial segments were determined in vitro and were related to histological results., Results: DES- and BMS-treated arteries showed proneness to vasoconstriction 5 h post-PCI. The endothelium-dependent vasodilation was profoundly (p < 0.05) impaired early after PCI (9.8 ± 3.7%, 13.4 ± 9.2%, 5.7 ± 5.3%, and 7.6 ± 4.7% using plain balloon, DEB, BMS, and DES, respectively), as compared with controls (49.6 ± 9.5%), with slow recovery. In contrast to DES, the endothelium-related vasodilation of vessels treated with plain balloon, DEB, and BMS was increased at 1 month, suggesting enhanced endogenous nitric oxide production of the neointima. The endothelium-independent (vascular smooth muscle-related) vasodilation decreased significantly at 1 day, with slow normalization during FUP. All PCI-treated vessels exhibited imbalance between vasoconstriction-vasodilation, which was more pronounced in DES- and BMS-treated vessels. No correlation between histological parameters and vasomotor function was found, indicating complex interactions between the healing neoendothelium and smooth muscle post-PCI., Conclusions: Coronary arteries treated with plain balloon, DEB, BMS, and DES showed time-dependent loss of endothelial-dependent and -independent vasomotor function, with imbalanced contraction/dilation capacity., (Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
16. Butyrylcholinesterase activity predicts long-term survival in patients with coronary artery disease.
- Author
-
Goliasch G, Haschemi A, Marculescu R, Endler G, Maurer G, Wagner O, Huber K, Mannhalter C, and Niessner A
- Subjects
- Acute Coronary Syndrome diagnosis, Acute Coronary Syndrome enzymology, Acute Coronary Syndrome mortality, Aged, Coronary Artery Disease enzymology, Coronary Artery Disease mortality, Female, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Survival Rate, Butyrylcholinesterase blood, Coronary Artery Disease diagnosis
- Abstract
Background: Low serum butyrylcholinesterase activity was associated with all-cause and cardiovascular mortality in a community-based study; however, there are no data from investigations of the long-term effects of butyrylcholinesterase on mortality in patients with diagnosed coronary artery disease (CAD). We therefore assessed the effect of butyrylcholinesterase activity on the outcomes of patients with CAD., Methods and Results: We prospectively included 720 patients in our study: 293 patients with stable CAD and 427 patients with acute coronary syndrome. During a median follow-up of 11.3 years corresponding to 6469 overall person-years, 278 deaths (38.6%) were recorded. We detected a significant and independent protective effect of butyrylcholinesterase on all-cause mortality [adjusted hazard ratio (HR) for a 1-SD increase, 0.62; 95% CI, 0.54-0.71; P < 0.001] and cardiovascular mortality (adjusted HR, 0.64; 95% CI, 0.54-0.76; P < 0.001) in a Cox proportional hazards regression analysis. The 10-year survival rates were 42%, 74%, and 87% in the first, second, and third tertiles of butyrylcholinesterase activity. The presentation of CAD affected the effect of butyrylcholinesterase on mortality (P for interaction = 0.012), with a stronger association found in patients with stable CAD (adjusted HR, 0.56; 95% CI, 0.45-0.70; P < 0.001)., Conclusions: Our study demonstrates a strong inverse association between butyrylcholinesterase activity and long-term outcome in patients with known CAD. Because butyrylcholinesterase added predictive information after adjustment for established cardiovascular risk factors, additional underlying pathophysiological mechanisms and the potential applicability of butyrylcholinesterase activity for secondary risk prediction needs to be addressed in future studies.
- Published
- 2012
- Full Text
- View/download PDF
17. Myocardial viability and survival in ischemic left ventricular dysfunction.
- Author
-
Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH, and Panza JA
- Subjects
- Aged, Cardiovascular Diseases mortality, Combined Modality Therapy, Coronary Artery Disease complications, Echocardiography, Stress, Female, Follow-Up Studies, Heart Failure drug therapy, Heart Failure etiology, Heart Failure surgery, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Myocardial Ischemia, Proportional Hazards Models, Statistics, Nonparametric, Tomography, Emission-Computed, Single-Photon, Ventricular Dysfunction, Left etiology, Coronary Artery Bypass, Coronary Artery Disease drug therapy, Coronary Artery Disease surgery, Myocardium pathology, Ventricular Dysfunction, Left drug therapy, Ventricular Dysfunction, Left surgery
- Abstract
Background: The assessment of myocardial viability has been used to identify patients with coronary artery disease and left ventricular dysfunction in whom coronary-artery bypass grafting (CABG) will provide a survival benefit. However, the efficacy of this approach is uncertain., Methods: In a substudy of patients with coronary artery disease and left ventricular dysfunction who were enrolled in a randomized trial of medical therapy with or without CABG, we used single-photon-emission computed tomography (SPECT), dobutamine echocardiography, or both to assess myocardial viability on the basis of prespecified thresholds., Results: Among the 1212 patients enrolled in the randomized trial, 601 underwent assessment of myocardial viability. Of these patients, we randomly assigned 298 to receive medical therapy plus CABG and 303 to receive medical therapy alone. A total of 178 of 487 patients with viable myocardium (37%) and 58 of 114 patients without viable myocardium (51%) died (hazard ratio for death among patients with viable myocardium, 0.64; 95% confidence interval [CI], 0.48 to 0.86; P=0.003). However, after adjustment for other baseline variables, this association with mortality was not significant (P=0.21). There was no significant interaction between viability status and treatment assignment with respect to mortality (P=0.53)., Conclusions: The presence of viable myocardium was associated with a greater likelihood of survival in patients with coronary artery disease and left ventricular dysfunction, but this relationship was not significant after adjustment for other baseline variables. The assessment of myocardial viability did not identify patients with a differential survival benefit from CABG, as compared with medical therapy alone. (Funded by the National Heart, Lung, and Blood Institute; STICH ClinicalTrials.gov number, NCT00023595.).
- Published
- 2011
- Full Text
- View/download PDF
18. The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤ 40 years of age).
- Author
-
Goliasch G, Wiesbauer F, Grafl A, Ponweiser E, Blessberger H, Tentzeris I, Wojta J, Schillinger M, Huber K, Maurer G, Mannhalter C, and Sunder-Plassmann R
- Subjects
- Adult, Alleles, Catheterization, Female, Homozygote, Humans, Male, Models, Statistical, Myocardial Infarction genetics, Polymerase Chain Reaction, Reactive Oxygen Species, Regression Analysis, Coronary Artery Disease genetics, NADPH Oxidases genetics, Polymorphism, Genetic
- Abstract
Acute myocardial infarction at a young age is associated with high morbidity and long-term mortality. The NADPH oxidase system as a main source of reactive oxygen species in vascular cells has been implicated in development and progression of coronary artery disease (CAD). In our study, we investigated the effect of polymorphisms in the p22-PHOX (CYBA) gene on CAD in young patients (≤ 40 years). We prospectively recruited 302 subjects into our multi-centre case control study, including 102 young myocardial infarction patients (≤ 40 years) from two high-volume cardiac catheterisation hospitals and frequency-matched them on age, gender, and center to 200 hospital controls in an approximate 2:1 ratio per case patient. The homozygote c.-930A>G promoter polymorphism was significantly more prevalent in the controls than in the infarction patients. In the adjusted logistic regression analysis, we detected a protective effect of the c.-930A>G promoter polymorphism against premature myocardial infarction. Using a log-additive/per-allele model, we detected an unadjusted odds ratio (OR) of 0.63 (95% confidence interval [CI] 0.45-0.9, p-value 0.011). In the adjusted model the association was more pronounced with an OR of 0.5 (95% CI 0.3-0.81, p-value 0.005). The C242T polymorphism and the 640A>G polymorphism did not differ significantly between the study groups. Furthermore we could not detect a significant effect for these polymorphisms in the logistic regression analysis. The present study suggests a protective association between the c.-930A>G promoter polymorphism in the p22-PHOX (CYBA) gene and the development of myocardial infarction in young individuals (≤ 40 years).
- Published
- 2011
- Full Text
- View/download PDF
19. Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9.
- Author
-
Katsaros KM, Kastl SP, Zorn G, Maurer G, Wojta J, Huber K, Christ G, and Speidl WS
- Subjects
- Cardiovascular Agents administration & dosage, Coronary Angiography, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease enzymology, Coronary Restenosis diagnostic imaging, Coronary Restenosis enzymology, Humans, Logistic Models, Odds Ratio, Paclitaxel administration & dosage, Prospective Studies, Risk Assessment, Risk Factors, Sirolimus administration & dosage, Time Factors, Treatment Outcome, Up-Regulation, Angioplasty, Balloon, Coronary adverse effects, Angioplasty, Balloon, Coronary instrumentation, Coronary Artery Disease therapy, Coronary Restenosis etiology, Drug-Eluting Stents, Matrix Metalloproteinase 2 blood, Matrix Metalloproteinase 9 blood
- Abstract
Objectives: Our aim was to test whether serum levels of matrix metalloproteinase (MMP)-2 and -9 are associated with the development of in-stent restenosis (ISR) after implantation of drug-eluting stents (DES)., Background: With the introduction of DES coronary ISR could be reduced dramatically. However, it still plays a significant role, particularly after treatment of multiple, complex lesions., Methods: We studied 85 patients who were treated with 159 DES. Blood samples for measurement of MMP-2 and -9 antigen and activity were taken directly before and 24 h after percutaneous coronary intervention (PCI). Restenosis was evaluated at 6 to 8 months by coronary angiography., Results: During the follow-up period, 2 patients (2.4%) died of cardiovascular causes, and 12 patients developed angiographic ISR. Patients with ISR showed significantly higher serum activity of MMP-9 at baseline (p = 0.017) and of MMP-2 (p < 0.0001) and MMP-9 (p < 0.0001) after the procedure. The PCI increased serum activity of MMP-2 (p = 0.005) and MMP-9 (p = 0.008) only in patients with ISR. The restenosis rates of patients in the highest quartile of MMP-2 after and MMP-9 before and after PCI were 40.0%, 38.9%, and 42.9% compared with 6.3%, 7.7%, and 4.0% in the lower quartiles, respectively. This was independent of clinical and procedural characteristics., Conclusions: Elevated serum activities of MMP-2 and -9 are associated with dramatically increased restenosis rates after PCI with implantation of DES. Determination of MMP levels might be useful for identification of patients who are at high risk for ISR despite implantation of DES., (Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
20. Premature compared with late onset of coronary artery disease: young patients show a severe defect in fibrinolytic response to venous occlusion.
- Author
-
Speidl WS, Nikfardjam M, Niessner A, Jordanova N, Zorn G, Maurer G, Schreiber W, Wojta J, and Huber K
- Subjects
- Adult, Age of Onset, Aged, Biomarkers blood, Coronary Artery Disease blood, Female, Humans, Inflammation blood, Male, Middle Aged, Myocardial Infarction, Thrombophilia blood, Coronary Artery Disease etiology, Fibrinolysis, Tissue Plasminogen Activator blood, Venous Thrombosis blood
- Abstract
Inflammatory processes play a role in the onset of acute cardiovascular events associated with activation of the coagulation system whereas the fibrinolytic system may prevent local thrombus formation. We compared 25 patients with premature coronary artery disease (CAD) (first ST-elevation myocardial infarction, < 55 years old) with 25 sex-matched patients older than 55 years at their first myocardial infarction. Six months after the acute event, patients with late onset of CAD showed a significantly higher increase of tissue-type plasminogen activator activity during venous occlusion compared with patients with premature CAD (P < 0.005). Prothrombin fragment 1+2 was higher in patients with late-onset CAD (P < 0.05), whereas the inflammatory markers C-reactive protein and soluble intercellular cell adhesion molecule-1 were not different in both groups. A multivariate analysis including cardiovascular risk factors showed that the tissue-type plasminogen activator response to venous occlusion was independently associated with patient age at onset of first ST-elevation myocardial infarction. Although in our series high age was associated with a prothrombotic state, a high fibrinolytic capacity might have some beneficial effect and contribute to a delayed onset of adverse cardiovascular events in these patients.
- Published
- 2007
- Full Text
- View/download PDF
21. Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort.
- Author
-
Szük T, Gyöngyösi M, Homorodi N, Kristóf E, Király C, Edes IF, Facskó A, Pavo N, Sodeck G, Strehblow C, Farhan S, Maurer G, Glogar D, Domanovits H, Huber K, and Edes I
- Subjects
- Clopidogrel, Combined Modality Therapy, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Preoperative Care, Prospective Studies, Registries, Ticlopidine administration & dosage, Time Factors, Treatment Outcome, Coronary Artery Disease drug therapy, Coronary Artery Disease surgery, Myocardial Revascularization, Platelet Aggregation Inhibitors administration & dosage, Stents, Ticlopidine analogs & derivatives
- Abstract
Background: The aim of our prospective multicenter Clopidogrel Registry was to evaluate the efficacy and safety of a 300-mg loading dose of clopidogrel at the time of ad hoc stenting in patients with suspected coronary artery disease who were not pretreated with clopidogrel for any reason, and to compare the 30-day clinical event rates with the outcome of patients pretreated with a loading dose of clopidogrel 6 to 24 hours before stenting., Methods: Between March 2002 and February 2004, 4160 consecutively included patients received a 300-mg loading dose of clopidogrel immediately after (group 1, n = 2679) or 6 to 24 hours before stenting (group 2, n = 1481)., Results: The primary end point (triple composite end point of acute myocardial infarction, all-cause death, and urgent repeat target vessel revascularization) at 30 days occurred in 4.74% versus 2.77% in groups 1 and 2, respectively (P = .002). The secondary end point events, the stent thrombosis, occurred significantly more frequently in group 1, with a trend toward increase in incidence of death, target vessel revascularization, or need for glycoprotein IIb/IIIa antagonists during percutaneous coronary intervention. Pretreatment with clopidogrel was associated with more major bleeding (secondary safety end point) (0.41% vs 1.35% in groups 1 and 2, respectively; P = .001)., Conclusions: The results of our multicenter prospective Clopidogrel Registry demonstrate lower efficacy of a 300-mg loading dose of clopidogrel at the time of stenting compared with pretreatment 6 to 24 hours before percutaneous coronary intervention on the 30-day composite clinical end point in the large unselected patient cohort, which suggests the benefit of clopidogrel pretreatment in all incoming patients with suspected significant coronary artery disease scheduled for coronary angiography.
- Published
- 2007
- Full Text
- View/download PDF
22. Assessment of myocardial perfusion by dynamic N-13 ammonia PET imaging: comparison of 2 tracer kinetic models.
- Author
-
Khorsand A, Graf S, Pirich C, Muzik O, Kletter K, Dudczak R, Maurer G, Sochor H, Schuster E, and Porenta G
- Subjects
- Adolescent, Adult, Aged, Computer Simulation, Female, Humans, Male, Middle Aged, Models, Cardiovascular, Nitrogen Radioisotopes, Radiopharmaceuticals, Reproducibility of Results, Sensitivity and Specificity, Ammonia, Coronary Artery Disease diagnostic imaging, Coronary Circulation, Coronary Vessels diagnostic imaging, Image Interpretation, Computer-Assisted methods, Positron-Emission Tomography methods, Radioisotope Dilution Technique
- Abstract
Background: Measurement of myocardial blood flow (MBF) by dynamic nitrogen 13 ammonia (NH(3)) positron emission tomography (PET) uses tracer kinetic modeling to analyze time-activity curves. We compared 2 commonly used models with 2 compartments (2C) and 3 compartments (3C) for quantification of MBF and coronary flow reserve (CFR)., Methods and Results: Seventy-seven patients underwent NH(3) PET at rest and during hyperemia. Time-activity curves for blood pool and myocardial segments were obtained from short-axis images of dynamic sequences. Model fitting of the 2C and 3C models was performed to estimate regional MBF. MBF values calculated by 2C and 3C models were 0.98 +/- 0.31 mL.min(-1).g(-1) and 1.11 +/- 0.37 mL.min(-1).g(-1), respectively, at rest (P < .0001) and 2.79 +/- 1.18 mL.min(-1).g(-1) and 2.46 +/- 1.02 mL.min(-1).g(-1), respectively, during hyperemia (P < .01), resulting in a CFR of 3.02 +/- 1.31 and 2.39 +/- 1.15 (P < .0001), respectively. Significant correlation was observed between the 2 models for calculation of resting MBF (r = 0.78), hyperemic MBF (r = 0.68), and CFR (r = 0.68)., Conclusion: Measurements of MBF and CFR by 2C and 3C models are significantly related. However, quantification of MBF and CFR significantly differs between the methods. This difference needs to be considered when normal values are established or when measurements obtained with different methods need to be compared.
- Published
- 2005
- Full Text
- View/download PDF
23. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
- Author
-
Niessner A, Marculescu R, Haschemi A, Endler G, Zorn G, Weyand CM, Maurer G, Mannhalter C, Wojta J, Wagner O, and Huber K
- Subjects
- Acute Disease, Adult, Aged, Alleles, C-Reactive Protein chemistry, C-Reactive Protein genetics, C-Reactive Protein metabolism, CX3C Chemokine Receptor 1, Cardiovascular Diseases genetics, Carrier Proteins chemistry, Chemokine CX3CL1, Chemokines, CX3C metabolism, Codon, Female, Gene Frequency, Genotype, Haplotypes, Heterozygote, Humans, Leukocytes metabolism, Ligands, Male, Membrane Proteins metabolism, Middle Aged, Multivariate Analysis, Prevalence, Receptors, Cytokine genetics, Receptors, Cytokine physiology, Receptors, HIV genetics, Receptors, HIV physiology, Risk, Risk Factors, Sensitivity and Specificity, Chemokines, CX3C genetics, Coronary Artery Disease genetics, Genetic Predisposition to Disease, Inflammation pathology, Membrane Proteins genetics, Polymorphism, Genetic, Receptors, Chemokine genetics
- Abstract
Several lines of evidence suggest that the chemokine fractalkine (FKN) and its receptor CX3CR1 contribute to the accumulation of leukocytes in the atherosclerotic plaque. The M280 allele of the CX3CR1T280M polymorphism modulates leukocyte recruitment and is associated with lower prevalence of cardiovascular disease. The influence of V249I, another CX3CR1 polymorphism, is discussed controversially. We investigated the association of the alleles M280 and I249 of CX3CR1 with coronary artery disease (CAD) and with acute coronary syndrome (ACS). Additionally, we assessed their association with the soluble ligand FKN and inflammatory activation measured by high sensitivity C-reactive protein (hsCRP). The genotypes of the V249I and T280M polymorphisms were determined in 1152 patients with suspected CAD.720 (62.5%) individuals showed significant CAD with an ACS prevalence of 59.3%. Using multivariate regression, we found a harmful influence of I249 (adjusted OR=1.8, P<0.03) and a protective effect of M280 (adjusted OR=0.6, P<0.04) on the occurrence of ACS in patients with CAD. Correspondingly, patients with I249 but without M280 (17%) were at elevated risk of ACS (OR=1.6, P<0.04). During ACS these patients (carrying only I249) had significantly higher circulating concentrations of FKN and high sensitivity C-reactive protein (1.9- and 1.6-fold). We found no association of the I249 or the M280 allele with the occurrence of CAD. In conclusion, I249 and M280 have opposite effects on the occurrence of ACS. The presence of I249 not "balanced" by M280 confers an elevated risk of ACS. A FKN-mediated enhanced inflammatory activation might explain this increased risk.
- Published
- 2005
- Full Text
- View/download PDF
24. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
- Author
-
Speidl WS, Zeiner A, Nikfardjam M, Geppert A, Jordanova N, Niessner A, Zorn G, Maurer G, Schreiber W, Wojta J, and Huber K
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Multivariate Analysis, Plasminogen Activator Inhibitor 1 blood, Tissue Plasminogen Activator blood, C-Reactive Protein analysis, Coronary Artery Disease blood, Endothelium, Vascular physiopathology, Fibrinolysis physiology, Myocardial Infarction blood
- Abstract
Objectives: The goal of this study was to determine whether chronic inflammation of the vascular wall may be associated with an impaired activation of the fibrinolytic system., Background: Inflammation plays an important role in the initiation and progression of atherosclerosis, and the fibrinolytic system may prevent local thrombus formation., Methods: We included 50 patients six months after their first myocardial infarction. Plasma levels of the inflammatory marker C-reactive protein (CRP) were determined at basal conditions, and the fibrinolytic parameters tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor type-1 (PAI-1) were measured at basal conditions and after a standardized venous occlusion (VO) of the forearm., Results: Patients with high CRP levels (> or =3 mg/l) showed a significantly higher t-PA activity at baseline compared with patients with medium (1 to 2.9 mg/l) and low (<1 mg/l) CRP levels (p <0.005). In contrast, patients with low CRP levels showed a higher increase of t-PA activity (p <0.05) and a higher reduction of PAI-1 activity during VO (p <0.05) compared with patients with medium and high CRP levels. A multivariate analysis that included cardiovascular risk factors and medical treatment showed that CRP is an independent predictor of the t-PA response after a standardized VO., Conclusions: Chronic low-grade inflammation is associated with enhanced activation of endogenous fibrinolysis at baseline but a reduced fibrinolytic response to VO. This impaired endogenous fibrinolytic capacity might be an important contributor to the increased coronary event rate associated with elevated CRP levels.
- Published
- 2005
- Full Text
- View/download PDF
25. Noninvasive ultrasound techniques for the assessment of atherosclerosis in coronary artery disease.
- Author
-
Neunteufl T and Maurer G
- Subjects
- Arteriosclerosis physiopathology, Coronary Artery Disease physiopathology, Elasticity, Endothelium, Vascular pathology, Endothelium, Vascular physiopathology, Humans, Prognosis, Vasodilation, Arteriosclerosis diagnostic imaging, Coronary Artery Disease diagnostic imaging, Ultrasonography methods
- Published
- 2003
- Full Text
- View/download PDF
26. Intracoronary thrombectomy with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome: a prospective, randomized, controlled study.
- Author
-
Beran G, Lang I, Schreiber W, Denk S, Stefenelli T, Syeda B, Maurer G, Glogar D, and Siostrzonek P
- Subjects
- Acute Disease, Blood Flow Velocity, Coronary Angiography, Coronary Circulation, Embolism prevention & control, Female, Humans, Male, Microcirculation physiopathology, Middle Aged, Multivariate Analysis, Odds Ratio, Prospective Studies, Rheology, Thrombectomy methods, Treatment Outcome, Angioplasty, Balloon, Coronary, Coronary Artery Disease surgery, Coronary Vessels physiopathology, Coronary Vessels surgery, Electrocardiography, Thrombectomy instrumentation
- Abstract
Background: In patients with acute coronary syndrome (ACS), percutaneous coronary intervention (PCI) may cause thrombus dislodgment followed by reduced flow and impaired microcirculatory function. We prospectively compared conventional PCI to a strategy of additional pretreatment using the X-sizer thrombectomy system., Methods and Results: Sixty-six patients (51 [77%] men; 54.9+/-9.9 years) with ACS (49 with ST-elevation infarction [STEMI]) and suspected intracoronary thrombus were randomized 1:1 to pretreatment with X-sizer and conventional PCI alone. Various aspects of epicardial flow and microvascular function were studied. Baseline data were similar in both groups. Postprocedural TIMI 3 flow was obtained in 90% of X-sizer-treated patients and in 84% of controls (NS); however, corrected TIMI frame count was lower in X-sizer- treated patients (18.3+/-10.2 versus 24.7+/-14.1; P<0.05). No significant group differences were observed in final coronary flow reserve, myocardial blush grade, and myocardial dye intensity. In STEMI, the sum of ST elevation was significantly lower in X-sizer-treated patients immediately after (2.78+/-3.05 versus 6.15+/-6.32 mm; P<0.03) and 6 hours after (2.17+/-2.31 versus 4.14+/-3.7 mm; P<0.05) intervention. ST-segment resolution >50% was observed in 83% of X-sizer-treated patients and in 52% of controls (P<0.03). Multivariate analysis identified X-sizer treatment as the single independent predictor of ST-segment resolution >50% (OR 4.35; 95% CI, 1.13 to 16.9; P<0.04). Major adverse cardiac events after 30 days occurred in 2 patients in each group., Conclusions: In ACS with suspected thrombus, pretreatment with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution compared with conventional PCI alone.
- Published
- 2002
- Full Text
- View/download PDF
27. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque.
- Author
-
Bonderman D, Teml A, Jakowitsch J, Adlbrecht C, Gyöngyösi M, Sperker W, Lass H, Mosgoeller W, Glogar DH, Probst P, Maurer G, Nemerson Y, and Lang IM
- Subjects
- Angioplasty adverse effects, Animals, Blood Flow Velocity physiology, Carotid Stenosis etiology, Carotid Stenosis metabolism, Carotid Stenosis physiopathology, Coronary Artery Disease etiology, Coronary Artery Disease physiopathology, Humans, Immunohistochemistry, Injections, Intra-Arterial, Models, Animal, Stents adverse effects, Swine, Thromboplastin metabolism, Thromboplastin pharmacology, Coronary Artery Disease metabolism, Coronary Circulation physiology, Hemostasis physiology, Thromboplastin physiology
- Abstract
Defined angiographically, no-reflow (NR) manifests as an acute reduction in coronary flow in the absence of epicardial vessel obstruction. One candidate protein to cause coronary NR is tissue factor (TF), which is abundant in atherosclerotic plaque and a cofactor for activated plasma coagulation factor VII. Scrapings from atherosclerotic carotid arteries contained TF activity (corresponding to 33.03 +/- 13.00 pg/cm(2) luminal plaque surface). Active TF was sedimented, indicating that TF was associated with membranes. Coronary blood was drawn from 6 patients undergoing coronary interventions with the distal protection device PercuSurge GuardWire (Traatek, Miami, FL). Fine particulate material that was recovered from coronary blood showed TF activity (corresponding to 91.1 +/- 62.16 pg/mL authentic TF). To examine the role of TF in acute coronary NR, blood was drawn via a catheter from coronary vessels in 13 patients during NR and after restoration of flow. Mean TF antigen levels were elevated during NR (194.3 +/- 142.8 pg/mL) as compared with levels after flow restoration (73.27 +/- 31.90 pg/mL; P =.02). To dissect the effects of particulate material and purified TF on flow, selective intracoronary injection of atherosclerotic material or purified relipidated TF was performed in a porcine model. TF induced NR in the model, thus strengthening the concept that TF is causal, not just a bystander to atherosclerotic plaque material. The data suggest that active TF is released from dissected coronary atherosclerotic plaque and is one of the factors causing the NR phenomenon. Thus, blood-borne TF in the coronary circulation is a major determinant of flow.
- Published
- 2002
- Full Text
- View/download PDF
28. Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels.
- Author
-
Wonnerth, Anna, Katsaros, Katharina M., Krychtiuk, Konstantin A., Speidl, Walter S., Kaun, Christoph, Thaler, Kylie, Huber, Kurt, Wojta, Johann, Maurer, Gerald, Seljeflot, Ingebjorg, Arnesen, Harald, and Weiss, Thomas W.
- Subjects
GLYCOPROTEINS ,CHROMOSOME polymorphism ,INTERLEUKIN-6 ,INFLAMMATION ,CELLULAR signal transduction ,MULTIVARIATE analysis ,BODY mass index - Abstract
Abstract: Objective: Interleukin-6 (IL-6) is a key cytokine in inflammatory diseases. It exerts its biological function via binding to a homodimer of its signal transducer glycoprotein 130 (gp130). Soluble gp130 (sgp130) is the natural inhibitor of IL-6 trans-signalling. The aim of this study was to test a possible influence of the gp130 genotype on sgp130 serum levels. Material and methods: In two separate populations, subjects were genotyped for the gp130 polymorphism G148C. Sgp130, IL-6 and soluble interleukin-6 receptor (sIL-6R) levels were measured. The OSLO population consisted of 546 male subjects at high risk for CAD. The VIENNA population consisted of 299 male subjects with angiographically proven CAD. Results: In the OSLO population, 124 (22.7%) subjects were hetero- or homozygote for the rare C allele. Individuals carrying the polymorphism had significantly higher levels of sgp130. In a multivariate linear regression model this association remained significant (adjusted p=0.001). In the VIENNA population, 48 (16.1%) subjects were hetero- or homozygote for the rare C allele. Consistent with the former study, sgp130 levels were significantly higher in carriers of the polymorphism compared to wildtype carriers (adjusted p=0.038). In the VIENNA population, sgp130 levels were significantly higher in diabetic patients. In the OSLO population, sgp130 was higher in patients with increased body mass index and in smokers (p<0.05). Conclusions: Sgp130 serum levels are significantly higher in subjects carrying the gp130 polymorphism G148C compared to wildtype carriers. This finding proposes a possible genetical influence on sgp130 levels which may alter individual coping mechanisms in inflammatory diseases. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
29. Functional Assessment of Coronary Arteries by Poststenotic Intravascular Doppler Ultrasound.
- Author
-
Porenta, Gerold, Binder, Thomas, Moertl, Deddo, Zehetgruber, Manfred, Graf, Senta, Maurer, Gerald, and Probst, Peter
- Subjects
DOPPLER ultrasonography ,CORONARY disease ,BLOOD pressure ,BLOOD flow measurement ,BLOOD vessels - Abstract
This study sought to delineate the impact of the rate pressure product on intraluminal Doppler velocity measurements and to determine the relation between poststenotic vasodilator reserve and percent luminal obstruction in coronary vessels. Twenty patients with single-vessel coronary disease were studied prior to coronary angioplasty and at follow-up 6 months later. Intracoronary velocity reserve after administration of adenosine was measured distal to the stenosis with a Doppler-tipped guide wire and was compared to quantitative coronary angiography and adenosine myocardial perfusion scintigraphy. The rate pressure product was confirmed as significant covariate (ANCOVA, p < 0.005) of intracoronary Doppler reserve. When normalized to rate pressure product, poststenotic Doppler velocity reserve in stenosed arteries was significantly lower than in patent arteries as classified by quantitative coronary angiography (1.7 ± 0.6 vs. 2.9 ± 0.5, p < 0.001) and perfusion scintigraphy (1.5 ± 0.4 vs. 2.8 ± 0.5, p < 0.001). Normalized Doppler velocity reserve showed a nonlinear but highly significant relation to percent area stenosis [y = 3.0·(1 – exp[0.081 (x – 100)]), p < 0.001]. When normalized Doppler velocity reserve was less than 2.0, coronary disease was identified with 95% specificity and 94% sensitivity in comparison to perfusion scintigraphy. Thus, in coronary arteries poststenotic Doppler reserve and percent area stenosis show a significant nonlinear relation. Doppler velocity reserve when normalized to rate pressure product can be used to characterize the hemodynamic impact of coronary obstructions. Copyright © 2000 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
30. Transesophageal versus intracoronary Doppler measurements for calculation of coronary flow reserve1.
- Author
-
Zehetgruber, Manfred, Porenta, Gerold, Mundigler, Gerald, Mörtl, Deddo, Binder, Thomas, Christ, Günter, Probst, Peter, Baumgartner, Helmut, Maurer, Gerald, and Siostrzonek, Peter
- Abstract
Objective: The present study was performed to compare coronary flow reserve by transesophageal Doppler echocardiography and intracoronary Doppler flow wire measurements in patients with LAD disease. Methods: 17 patients with various degree of LAD stenosis were studied. Intracoronary LAD Doppler measurements were performed at baseline and after intracoronary injection of 18 μg adenosine. Transesophageal coronary sinus and LAD Doppler measurements were performed at baseline and after intravenous dipyridamole (0.6 mg/kg/5 min). Coronary flow reserve was calculated as the ratio of hyperemic to baseline average peak velocities. Results: Coronary flow reserve was 2.44±0.62 and 2.19±0.76 for proximal and distal intracoronary measurements and was 2.25±0.64 and 1.74±0.63 for transesophageal LAD- and coronary sinus measurements. Proximal intracoronary flow reserve significantly correlated with transesophageal coronary sinus (r = 0.73, p≤0.001) and LAD (r = 0.70, p≤0.005) measurements, whereas distal intracoronary flow reserve only correlated with transesophageal coronary sinus flow reserve (r = 0.56, p≤0.02). Receiver operating characteristic curve analysis demonstrated similar diagnostic accuracy of all applied techniques for detection of a significant LAD stenosis. Conclusions: Coronary flow reserve by both transesophageal techniques correlated with intracoronary Doppler flow wire measurements, however considerable discrepancies may occur in the individual patient. [ABSTRACT FROM PUBLISHER]
- Published
- 1997
- Full Text
- View/download PDF
31. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction
- Author
-
Speidl, Walter Stefan, Nikfardjam, Mariam, Niessner, Alexander, Zeiner, Andrea, Jordanova, Nelli, Zorn, Gerlinde, Maurer, Gerald, Schreiber, Wolfgang, Wojta, Johann, and Huber, Kurt
- Subjects
- *
MYOCARDIAL infarction , *CORONARY disease , *PROTEOLYTIC enzymes , *HOMOCYSTEINE - Abstract
Abstract: Background: Elevated homocysteine (Hcy) levels have been associated with increased risk for cardiovascular disease and it has been shown that hyperhomocysteinemia is associated with increased levels of t-PA antigen in individuals without evidence for coronary artery disease (CAD). The aim of this study was to examine if Hcy plasma levels are associated with plasma levels of fibrinolytic factors in patients with CAD and a history of acute myocardial infarction. Methods: We measured in 56patients with CAD, 1month after their first ST-elevation myocardial infarction, plasma levels of Hcy, the fibrinolytic parameters tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor-type-1 (PAI-1), and t-PA–PAI-1 complexes. Results: Hcy plasma levels inversely correlated with t-PA activity (r =−0.303, p <0.05). Patients with mild hyperhomocysteinemia (Hcy>15μmol/L, n =8) showed significantly lower plasma levels of t-PA activity (p <0.05). Regression analysis revealed that out of cardiovascular risk factors and medical treatment only Hcy was significantly associated with t-PA activity. Conclusions: Patients with CAD after a first myocardial infarction and hyperhomocysteinemia show a reduced t-PA activity independently from cardiovascular risk factors and medical treatment. Homocysteine lowering therapies may increase fibrinolytic activity and thereby may help to avoid atherothrombotic events in patients with CAD after a first myocardial infarction. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.